Diseases caused by mutations in ORAI1 and STIM1

Annals of the New York Academy of Sciences

Volumn 1356, Issue 1, 2015, Pages 45-79

  Lacruz, Rodrigo S ^a   Feske, Stefan ^b  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ameloblast; Autoimmunity; Ca2+; Calcium; Channelopathy; CRAC channel; Disease; Enamel; Muscular hypotonia; Mutation; ORAI1; Platelets; Skeletal muscle; SOCE; STIM1; Stormorken syndrome; Thrombocytopenia; Tubular aggregate myopathy; York platelet syndrome

Indexed keywords

CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; STROMAL INTERACTION MOLECULE 1; CALCIUM CHANNEL; MEMBRANE PROTEIN; ORAI1 PROTEIN, HUMAN; STIM1 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; AUTOIMMUNITY; CALCIUM TRANSPORT; CHANNELOPATHY; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; LOSS OF FUNCTION MUTATION; MUSCLE HYPOTONIA; NONHUMAN; PHENOTYPE; REGULATORY MECHANISM; STORMORKEN SYNDROME; SYNDROME; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; TOOTH DEVELOPMENT; YORK PLATELET SYNDROME; AUTOIMMUNE DISEASE; GENETICS; IMMUNOLOGY; MUTATION; PATHOLOGY; SEVERE COMBINED IMMUNODEFICIENCY;

AUTOIMMUNE DISEASES; CALCIUM CHANNELS; CHANNELOPATHIES; HUMANS; MEMBRANE PROTEINS; MUSCLE HYPOTONIA; MUTATION; NEOPLASM PROTEINS; ORAI1 PROTEIN; SEVERE COMBINED IMMUNODEFICIENCY; STROMAL INTERACTION MOLECULE 1;

EID: 84948737202     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12938     Document Type: Article

References (167)

1. Feske, S., Y. Gwack, M. Prakriya, et al. 2006. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179-185.
2. 2+ stores. Proc. Natl. Acad. Sci. U. S. A. 90: 6295-6299.
3. Hoth, M. & R. Penner. 1992. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355: 353-356.
4. 2+ current in human leukemic T cells. Cell Regul. 1: 99-112.
5. Prakriya, M. & R.S. Lewis. 2003. CRAC channels: activation, permeation, and the search for a molecular identity. Cell Calcium 33: 311-321.
6. 2+ entry. J. Biol. Chem. 281: 35855-35862.
7. Stathopulos, P.B., L. Zheng, G.Y. Li, et al. 2008. Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell 135: 110-122.
8. 2+ influx. Curr. Biol. 15: 1235-1241.
9. Spassova, M.A., J. Soboloff, L.P. He, et al. 2006. STIM1 has a plasma membrane role in the activation of store-operated Ca(2+) channels. Proc. Natl. Acad. Sci. U. S. A. 103: 4040-4045.
10. 2+ store to the plasma membrane. Nature 437: 902-905.
11. Grosse, J., A. Braun, D. Varga-Szabo, et al. 2007. An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice. J. Clin. Invest. 117: 3540-3550.
12. Bohm, J., F. Chevessier, C. Koch, et al. 2014. Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1. J. Med. Genet. 51: 824-833.
13. Bohm, J., F. Chevessier, A. Maues De Paula, et al. 2013. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am. J. Hum. Genet. 92: 271-278.
14. Walter, M.C., M. Rossius, M. Zitzelsberger, et al. 2015. 50 years to diagnosis: autosomal dominant tubular aggregate myopathy caused by a novel STIM1 mutation. Neuromuscul. Disord. 25: 577-584.
15. Zhou, Y., P. Srinivasan, S. Razavi, et al. 2013. Initial activation of STIM1, the regulator of store-operated calcium entry. Nat. Struct. Mol. Biol. 20: 973-981.
16. Park, C.Y., P.J. Hoover, F.M. Mullins, et al. 2009. STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 136: 876-890.
17. Yuan, J.P., W. Zeng, M.R. Dorwart, et al. 2009. SOAR and the polybasic STIM1 domains gate and regulate Orai channels. Nat. Cell Biol. 11: 337-343.
18. Kawasaki, T., I. Lange & S. Feske. 2009. A minimal regulatory domain in the C terminus of STIM1 binds to and activates ORAI1 CRAC channels. Biochem. Biophys. Res. Commun. 385: 49-54.
19. Covington, E.D., M.M. Wu & R.S. Lewis. 2010. Essential role for the CRAC activation domain in store-dependent oligomerization of STIM1. Mol. Biol. Cell 21: 1897-1907.
20. 2+ influx by interacting with the C-terminal acidic coiled coil of Orai1. Biochemistry 49: 1067-1071.
21. Korzeniowski, M.K., I.M. Manjarres, P. Varnai & T. Balla. 2010. Activation of STIM1-Orai1 involves an intramolecular switching mechanism. Sci. Signal. 3: ra82.
22. 2+ entry. Science 312: 1220-1223.
23. Zhang, S.L., A.V. Yeromin, X.H. Zhang, et al. 2006. Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc. Natl. Acad. Sci. U. S. A. 103: 9357-9362.
24. Parekh, A.B. & R. Penner. 1997. Store depletion and calcium influx. Physiol. Rev. 77: 901-930.
25. Shaw, P.J., B. Qu, M. Hoth & S. Feske. 2013. Molecular regulation of CRAC channels and their role in lymphocyte function. Cell. Mol. Life Sci. 70: 2637-2656.
26. McNally, B.A., M. Yamashita, A. Engh & M. Prakriya. 2009. Structural determinants of ion permeation in CRAC channels. Proc. Natl. Acad. Sci. U. S. A. 106: 22516-22521.
27. Zhou, Y., S. Ramachandran, M. Oh-Hora, et al. 2010. Pore architecture of the ORAI1 store-operated calcium channel. Proc. Natl. Acad. Sci. U. S. A. 107: 4896-4901.
28. Prakriya, M., S. Feske, Y. Gwack, et al. 2006. Orai1 is an essential pore subunit of the CRAC channel. Nature 443: 230-233.
29. Yeromin, A.V., S.L. Zhang, W. Jiang, et al. 2006. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 443: 226-229.
30. Derler, I., M. Fahrner, O. Carugo, et al. 2009. Increased hydrophobicity at the N-terminus/membrane interface impairs gating of the SCID-related ORAI1 mutant. J. Biol. Chem. 284: 15903-15915.
31. Hou, X., L. Pedi, M.M. Diver & S.B. Long. 2012. Crystal structure of the calcium release-activated calcium channel Orai. Science 338: 1308-1313.
32. Ji, W., P. Xu, Z. Li, et al. 2008. Functional stoichiometry of the unitary calcium-release-activated calcium channel. Proc. Natl. Acad. Sci. U. S. A. 105: 13668-13673.
33. Mignen, O., J.L. Thompson & T.J. Shuttleworth. 2008. Orai1 subunit stoichiometry of the mammalian CRAC channel pore. J. Physiol. 586: 419-425.
34. Penna, A., A. Demuro, A.V. Yeromin, et al. 2008. The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature 456: 116-120.
35. Muik, M., I. Frischauf, I. Derler, et al. 2008. Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J. Biol. Chem. 283: 8014-8022.
36. Navarro-Borelly, L., A. Somasundaram, M. Yamashita, et al. 2008. STIM1-Orai1 interactions and Orai1 conformational changes revealed by live-cell FRET microscopy. J. Physiol. 586: 5383-5401.
37. Lewis, R.S. 2011. Store-operated calcium channels: new perspectives on mechanism and function. Cold Spring Harb. Perspect. Biol. 3.
38. Hogan, P.G., R.S. Lewis & A. Rao. 2010. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 28: 491-533.
39. 2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J. Allergy Clin. Immunol. 124: 1311-1318.e7.
40. Picard, C., C.A. McCarl, A. Papolos, et al. 2009. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N. Engl. J. Med. 360: 1971-1980.
41. + channel gating in T cells from immunodeficient patients. J. Exp. Med. 202: 651-662.
42. Schaballie, H., R. Rodriguez, E. Martin, et al. 2015. A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency. J. Allergy Clin. Immunol. 136: 816-819.e4.
43. Fahrner, M., M. Muik, R. Schindl, et al. 2014. A coiled-coil clamp controls both conformation and clustering of stromal interaction molecule 1 (STIM1). J. Biol. Chem. 289: 33231-33244.
44. Maus, M., A. Jairaman, P.B. Stathopulos, et al. 2015. Missense mutation in immunodeficient patients shows the multifunctional roles of coiled-coil domain 3 (CC3) in STIM1 activation. Proc. Natl. Acad. Sci. U. S. A. 112: 6206-6211.
45. Fuchs, S., A. Rensing-Ehl, C. Speckmann, et al. 2012. Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J. Immunol. 188: 1523-1533.
46. Muik, M., M. Fahrner, R. Schindl, et al. 2011. STIM1 couples to ORAI1 via an intramolecular transition into an extended conformation. EMBO J. 30: 1678-1689.
47. 2+ stores and on electrostatic interactions. Mol. Biol. Cell 20: 389-399.
48. 2+ entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J. Cell Biol. 174: 815-825.
49. Li, Z., L. Liu, Y. Deng, et al. 2011. Graded activation of CRAC channel by binding of different numbers of STIM1 to Orai1 subunits. Cell Res. 21: 305-315.
50. 2+ (CRAC) channels by stromal interaction molecule 1 (STIM1). Proc. Natl. Acad. Sci. U. S. A. 108: 13299-13304.
51. Luik, R.M., B. Wang, M. Prakriya, et al. 2008. Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation. Nature 454: 538-542.
52. Muik, M., M. Fahrner, I. Derler, et al. 2009. A cytosolic homomerization and a modulatory domain within STIM1 C terminus determine coupling to ORAI1 channels. J. Biol. Chem. 284: 8421-8426.
53. Zhou, Y., P. Meraner, H.T. Kwon, et al. 2010. STIM1 gates the store-operated calcium channel ORAI1 in vitro. Nat. Struct. Mol. Biol. 17: 112-116.
54. Stathopulos, P.B., R. Schindl, M. Fahrner, et al. 2013. STIM1/Orai1 coiled-coil interplay in the regulation of store-operated calcium entry. Nat. Commun. 4: 2963.
55. Wang, S., M. Choi, A.S. Richardson, et al. 2014. STIM1 and SLC24A4 are critical for enamel maturation. J. Dent. Res. 93(Suppl.): 94S-100S.
56. 2+ entry in the immune system and beyond. Immunol. Rev. 231: 189-209.
57. Feske, S. 2010. CRAC channelopathies. Pflugers Arch. 460: 417-435.
58. Feske, S. 2011. Immunodeficiency due to defects in store-operated calcium entry. Ann. N. Y. Acad. Sci. 1238: 74-90.
59. Byun, M., A. Abhyankar, V. Lelarge, et al. 2010. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J. Exp. Med. 207: 2307-2312.
60. Sahin, G., A. Palanduz, G. Aydogan, et al. 2010. Classic Kaposi sarcoma in 3 unrelated Turkish children born to consanguineous kindreds. Pediatrics 125: e704-708.
61. Feske, S., J.M. Muller, D. Graf, et al. 1996. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur. J. Immunol. 26: 2119-2126.
62. Oh-Hora, M., M. Yamashita, P.G. Hogan, et al. 2008. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat. Immunol. 9: 432-443.
63. Baba, Y., K. Nishida, Y. Fujii, et al. 2008. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat. Immunol. 9: 81-88.
64. Beyersdorf, N., A. Braun, T. Vogtle, et al. 2009. STIM1-independent T cell development and effector function in vivo. J. Immunol. 182: 3390-3397.
65. 2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J. Immunol. 185: 5845-5858.
66. Vig, M., W.I. DeHaven, G.S. Bird, et al. 2008. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat. Immunol. 9: 89-96.
67. Oh-Hora, M., N. Komatsu, M. Pishyareh, et al. 2013. Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. Immunity 38: 881-895.
68. Chou, J., Y.R. Badran, C.S.K. Yee, et al. 2015. A novel mutation in ORAI1 presenting with combined immunodeficiency and residual T cell function. J. Allergy Clin. Immunol. 136: 479-482.e1.
69. Shaw, P.J., C. Weidinger, M. Vaeth, et al. 2014. CD4(+) and CD8(+) T cell-dependent antiviral immunity requires STIM1 and STIM2. J. Clin. Invest. 124: 4549-4563.
70. Feske, S., J. Giltnane, R. Dolmetsch, et al. 2001. Gene regulation mediated by calcium signals in T lymphocytes. Nat. Immunol. 2: 316-324.
71. Le Deist, F., C. Hivroz, M. Partiseti, et al. 1995. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood 85: 1053-1062.
72. Maul-Pavicic, A., S.C. Chiang, A. Rensing-Ehl, et al. 2011. ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc. Natl. Acad. Sci. U. S. A. 108: 3324-3329.
73. Feske, S., R. Draeger, H.H. Peter, et al. 2000. The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells. J. Immunol. 165: 297-305.
74. Desvignes, L., C. Weidinger, P. Shaw, et al. 2015. STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection. J. Clin. Invest. 125: 2347-2362.
75. Kim, K.D., S. Srikanth, M.K. Yee, et al. 2011. ORAI1 deficiency impairs activated T cell death and enhances T cell survival. J. Immunol. 187: 3620-3630.
76. Weidinger, C., P.J. Shaw & S. Feske. 2013. STIM1 and STIM2-mediated Ca(2+) influx regulates antitumour immunity by CD8(+) T cells. EMBO Mol. Med. 5: 1311-1321.
77. + B cells: T-cell or TLR-dependent? Blood 120: 4905-4906.
78. + B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients. Blood 120: 4992-5001.
79. Schlesier, M., C. Niemeyer, U. Duffner, et al. 1993. Primary severe immunodeficiency due to impaired signal transduction in T cells. Immunodeficiency 4: 133-136.
80. Engelke, M., N. Engels, K. Dittmann, et al. 2007. Ca(2+) signaling in antigen receptor-activated B lymphocytes. Immunol. Rev. 218: 235-246.
81. Matsumoto, M., Y. Fujii, A. Baba, et al. 2011. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 34: 703-714.
82. Braun, A., J.E. Gessner, D. Varga-Szabo, et al. 2009. STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation. Blood 113: 1097-1104.
83. 2+ signaling and FcgammaR-mediated phagosomal oxidative activity. J. Immunol. 186: 2182-2191.
84. Zhang, H., R.A. Clemens, F. Liu, et al. 2014. STIM1 calcium sensor is required for activation of the phagocyte oxidase during inflammation and host defense. Blood 123: 2238-2249.
85. Felix, R., D. Crottes, A. Delalande, et al. 2013. The Orai-1 and STIM-1 complex controls human dendritic cell maturation. PLoS One 8: e61595.
86. 2+ hotspots that boost phagocytosis. Curr. Biol. 22: 1990-1997.
87. Connolly, S.F. & D.J. Kusner. 2007. The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens. Immunol. Res. 39: 115-127.
88. 2+ entry (SOCE) is required for the function of macrophages and dendritic cells. J. Immunol. 195: 1202-1217.
89. Steinckwich, N., P. Myers, K.S. Janardhan, et al. 2015. Role of the store-operated calcium entry protein, STIM1, in neutrophil chemotaxis and infiltration into a murine model of psoriasis-inflamed skin. FASEB J. 29: 3003-3013.
90. Sogkas, G., T. Vogtle, E. Rau, et al. 2015. Orai1 controls C5a-induced neutrophil recruitment in inflammation. Eur. J. Immunol. 45: 2143-2153.
91. Partiseti, M., F. Le Deist, C. Hivroz, et al. 1994. The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J. Biol. Chem. 269: 32327-32335.
92. Curotto de Lafaille, M.A. & J.J. Lafaille. 2009. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30: 626-635.
93. Misceo, D., A. Holmgren, W.E. Louch, et al. 2014. A dominant STIM1 mutation causes Stormorken syndrome. Hum. Mutat. 35: 556-564.
94. Morin, G., N.O. Bruechle, A.R. Singh, et al. 2014. Gain-of-function mutation in STIM1 (P.R304W) is associated with Stormorken syndrome. Hum. Mutat. 35: 1221-1232.
95. Nesin, V., G. Wiley, M. Kousi, et al. 2014. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Proc. Natl. Acad. Sci. U. S. A. 111: 4197-4202.
96. Stormorken, H., H. Holmsen, R. Sund, et al. 1995. Studies on the haemostatic defect in a complicated syndrome. An inverse Scott syndrome platelet membrane abnormality? Thromb. Haemost. 74: 1244-1251.
97. Ahmad, F., Y. Boulaftali, T.K. Greene, et al. 2011. Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis. J. Thromb. Haemost. 9: 2077-2086.
98. Varga-Szabo, D., A. Braun, C. Kleinschnitz, et al. 2008. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J. Exp. Med. 205: 1583-1591.
99. Braun, A., D. Varga-Szabo, C. Kleinschnitz, et al. 2009. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 113: 2056-2063.
100. Bergmeier, W., M. Oh-Hora, C.A. McCarl, et al. 2009. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 113: 675-678.
101. Nakamura, L., K. Sandrock-Lang, C. Speckmann, et al. 2013. Platelet secretion defect in a patient with stromal interaction molecule 1 deficiency. Blood 122: 3696-3698.
102. 2+ entry through STIM and ORAI proteins in immunity, hemostasis and cancer. Channels (Austin) 7: 379-391.
103. Gilio, K., R. van Kruchten, A. Braun, et al. 2010. Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J. Biol. Chem. 285: 23629-23638.
104. Darbousset, R., G.M. Thomas, S. Mezouar, et al. 2012. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood 120: 2133-2143.
105. Jin, R., G. Yang & G. Li. 2010. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87: 779-789.
106. 2+ entry in muscle? Microcirculation 20: 330-336.
107. Williams, R.T., S.S. Manji, N.J. Parker, et al. 2001. Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem. J. 357(Pt 3): 673-685.
108. Stiber, J., A. Hawkins, Z.S. Zhang, et al. 2008. STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat. Cell Biol. 10: 688-697.
109. Wei-Lapierre, L., E.M. Carrell, S. Boncompagni, et al. 2013. Orai1-dependent calcium entry promotes skeletal muscle growth and limits fatigue. Nat. Commun. 4: 2805.
110. 2+ entry into mouse skeletal muscle fibres. J. Physiol. 533: 185-199.
111. 2+ entry in skeletal muscle. Pflugers Arch. 460: 813-823.
112. Darbellay, B., S. Arnaudeau, D. Ceroni, et al. 2010. Human muscle economy myoblast differentiation and excitation-contraction coupling use the same molecular partners, STIM1 and STIM2. J. Biol. Chem. 285: 22437-22447.
113. Darbellay, B., S. Arnaudeau, S. Konig, et al. 2009. STIM1- and Orai1-dependent store-operated calcium entry regulates human myoblast differentiation. J. Biol. Chem. 284: 5370-5380.
114. Hogan, P. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17: 2205-2232.
115. Pan, Z., D. Yang, R.Y. Nagaraj, et al. 2002. Dysfunction of store-operated calcium channel in muscle cells lacking mg29. Nat. Cell Biol. 4: 379-383.
116. Smith, C.E. 1998. Cellular and chemical events during enamel maturation. Crit. Rev. Oral Biol. Med. 9: 128-161.
117. Simmer, J.P. & A.G. Fincham. 1995. Molecular mechanisms of dental enamel formation. Crit. Rev. Oral Biol. Med. 6: 84-108.
118. Lacruz, R.S., C.E. Smith, I. Kurtz, et al. 2013. New paradigms on the transport functions of maturation-stage ameloblasts. J. Dent. Res. 92: 122-129.
119. Hu, P., R.S. Lacruz, C.E. Smith, et al. 2012. Expression of the sodium/calcium/potassium exchanger, NCKX4, in ameloblasts. Cells Tissues Organs 196: 501-509.
120. Bawden, J.W. 1989. Calcium transport during mineralization. Anat. Rec. 224: 226-233.
121. Okumura, R., Y. Shibukawa, T. Muramatsu, et al. 2010. Sodium-calcium exchangers in rat ameloblasts. J. Pharmacol. Sci. 112: 223-230.
122. Parry, D.A., J.A. Poulter, C.V. Logan, et al. 2013. Identification of mutations in SLC24A4, encoding a potassium-dependent sodium/calcium exchanger, as a cause of amelogenesis imperfecta. Am. J. Hum. Genet. 92: 307-312.
123. Hubbard, M.J. 1996. Abundant calcium homeostasis machinery in rat dental enamel cells. Up-regulation of calcium store proteins during enamel mineralization implicates the endoplasmic reticulum in calcium transcytosis. Eur. J. Biochem. 239: 611-623.
124. Hubbard, M.J. 2000. Calcium transport across the dental enamel epithelium. Crit. Rev. Oral Biol. Med. 11: 437-466.
125. Lacruz, R.S., C.E. Smith, P. Bringas, Jr., et al. 2012. Identification of novel candidate genes involved in mineralization of dental enamel by genome-wide transcript profiling. J. Cell. Physiol. 227: 2264-2275.
126. 2+ entry modulates the expression of enamel genes. J. Dent. Res. pii: 0022034515598144.
127. 2+-ATPase pump is up-regulated in calcium-transporting dental enamel cells: a non-housekeeping role for SERCA2b. Biochem. J. 358(Pt 1): 217-224.
128. Chen, J., Y. Zhang, J. Mendoza & P. Denbesten. 2009. Calcium-mediated differentiation of ameloblast lineage cells in vitro. J. Exp. Zool. B Mol. Dev. Evol. 312B: 458-464.
129. Bartlett, J.D., Z. Skobe, D.H. Lee, et al. 2006. A developmental comparison of matrix metalloproteinase-20 and amelogenin null mouse enamel. Eur. J. Oral Sci. 114(Suppl. 1): 18-23; discussion 39-41, 379.
130. Macian, F. 2005. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5: 472-484.
131. Zanotti, S. & E. Canalis. 2015. Activation of Nfatc2 in osteoblasts causes osteopenia. J. Cell. Physiol. 230: 1689-1695.
132. Sesler, C.L. & M. Zayzafoon. 2013. NFAT signaling in osteoblasts regulates the hematopoietic niche in the bone microenvironment. Clin. Dev. Immunol. 2013: 107321.
133. Kraus, B.S. & R.E. Jordan. 1965. The Human Dentition before Birth. Philadelphia:Lea & Febiger.
134. Markello, T., D. Chen, J.Y. Kwan, et al. 2015. York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1. Mol. Genet. Metab. 114: 474-482.
135. Stormorken, H., O. Sjaastad, A. Langslet, et al. 1985. A new syndrome: thrombocytopathia, muscle fatigue, asplenia, miosis, migraine, dyslexia and ichthyosis. Clin. Genet. 28: 367-374.
136. White, J.G. & G.G. Ahlstrand. 2003. Giant electron dense chains, clusters and granules in megakaryocytes and platelets with normal dense bodies: an inherited thrombocytopenic disorder IV. Ultrastructural cytochemistry and analytical electron microscopy. Platelets 14: 313-324.
137. White, J.G. & G.G. Ahlstrand. 2003. Giant electron dense chains, clusters and granules in megakaryocytes and platelets with normal dense bodies: an inherited thrombocytopenic disorder III. Platelet analytical electron microscopy. Platelets 14: 305-312.
138. White, J.G. 2003. Giant electron-dense chains, clusters and granules in megakaryocytes and platelets with normal dense bodies: an inherited thrombocytopenic disorder. Platelets 14: 109-121.
139. White, J.G. 2003. Giant electron-dense chains, clusters and granules in megakaryocytes and platelets with normal dense bodies: an inherited thrombocytopenic disorder I. Megakaryocytes. Platelets 14: 53-60.
140. 2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. J. Cell Biol. 174: 803-813.
141. Orci, L., M. Ravazzola, M. Le Coadic, et al. 2009. From the cover: STIM1-induced precortical and cortical subdomains of the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 106: 19358-19362.
142. Yang, X., H. Jin, X. Cai, et al. 2012. Structural and mechanistic insights into the activation of Stromal interaction molecule 1 (STIM1). Proc. Natl. Acad. Sci. U. S. A. 109: 5657-5662.
143. 2+ sensor STIM1 in an inactive conformation. J. Cell Sci. 126(Pt 11): 2401-2410.
144. Cui, B., X. Yang, S. Li, et al. 2013. The inhibitory helix controls the intramolecular conformational switching of the C-terminus of STIM1. PLoS One 8: e74735.
145. Feske, S. & M. Prakriya. 2013. Conformational dynamics of STIM1 activation. Nat. Struct. Mol. Biol. 20: 918-919.
146. Sjaastad, O., J. Aasly, H. Stormorken, et al. 1992. A new hereditary syndrome with a bleeding tendency, extreme miosis, spasms, dyslexia, thrombocytopathia etc. Pupillometric, evaporimetric, and ophthalmological observations. Acta Ophthalmol. 70: 713-720.
147. Mizobuchi, M., C. Tanaka, K. Sako, et al. 2000. [Muscle involvement of Stormorken's syndrome]. Rinsho Shinkeigaku 40: 915-920.
148. Chevessier, F., S. Bauche-Godard, J.P. Leroy, et al. 2005. The origin of tubular aggregates in human myopathies. J. Pathol. 207: 313-323.
149. Engel, W.K., D.W. Bishop & G.G. Cunningham. 1970. Tubular aggregates in type II muscle fibers: ultrastructural and histochemical correlation. J. Ultrastruct. Res. 31: 507-525.
150. Hedberg, C., M. Niceta, F. Fattori, et al. 2014. Childhood onset tubular aggregate myopathy associated with de novo STIM1 mutations. J. Neurol. 261: 870-876.
151. 2+ channels. Hum. Mol. Genet. 24: 637-648.
152. Zhang, S.L., A.V. Yeromin, J. Hu, et al. 2011. Mutations in Orai1 transmembrane segment 1 cause STIM1-independent activation of Orai1 channels at glycine 98 and channel closure at arginine 91. Proc. Natl. Acad. Sci. U. S. A. 108: 17838-17843.
153. 2+ (CRAC) channel activation. J. Biol. Chem. 288: 11263-11272.
154. Tieleman, D.P., I.H. Shrivastava, M.R. Ulmschneider & M.S. Sansom. 2001. Proline-induced hinges in transmembrane helices: possible roles in ion channel gating. Proteins 44: 63-72.
155. Thomas, D., M. Khalil, M. Alter, et al. 2010. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1. J. Mol. Cell. Cardiol. 48: 230-237.
156. Hermosura, M.C., A.M. Cui, R.C. Go, et al. 2008. Altered functional properties of a TRPM2 variant in Guamanian ALS and PD. Proc. Natl. Acad. Sci. U. S. A. 105: 18029-18034.
157. Saul, B., T. Kuner, D. Sobetzko, et al. 1999. Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia defines an intracellular determinant of glycine receptor channel gating. J. Neurosci. 19: 869-877.
158. Parekh, A.B. & R. Penner. 1995. Activation of store-operated calcium influx at resting InsP3 levels by sensitization of the InsP3 receptor in rat basophilic leukaemia cells. J. Physiol. 489(Pt 2): 377-382.
159. Zweifach, A. & R.S. Lewis. 1995. Slow calcium-dependent inactivation of depletion-activated calcium current. Store-dependent and -independent mechanisms. J. Biol. Chem. 270: 14445-14451.
160. 2+ overload. J. Cell Sci. 121(Pt 19): 3133-3139.
161. 2+ entry. J. Biol. Chem. 286: 36448-36459.
162. Shahrizaila, N., J. Lowe & A. Wills. 2004. Familial myopathy with tubular aggregates associated with abnormal pupils. Neurology 63: 1111-1113.
163. Schiaffino, S. 2012. Tubular aggregates in skeletal muscle: just a special type of protein aggregates? Neuromuscul. Disord. 22: 199-207.
164. 2+ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy. Hum. Mol. Genet. 23: 3706-3715.
165. Choi, S., J. Maleth, A. Jha, et al. 2014. The TRPCs-STIM1-Orai interaction. Handb. Exp. Pharmacol. 223: 1035-1054.
166. Wang, Y., X. Deng, S. Mancarella, et al. 2010. The calcium store sensor, STIM1, reciprocally controls Orai and CaV1.2 channels. Science 330: 105-109.
167. Park, C.Y., A. Shcheglovitov & R. Dolmetsch. 2010. The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 330: 101-105.